Follow The Filings

BCTX BriaCell Therapeutics

BriaCell Therapeutics earnings company data as of 11:58 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 21 Oct EPS — — —
Rev — — —

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 7.01,9.01
10-Q
8-K 1.01,3.02,8.01,9.01
424B5
8-K 7.01,9.01
10-Q
8-K 5.07
8-K 8.01,9.01
DEF 14A
SCHEDULE 13G —
8-K 1.01,8.01,9.01
424B4
8-K 7.01,9.01
S-1
10-Q
8-K 7.01,9.01
SCHEDULE 13G/A —
10-K
SCHEDULE 13G —
8-K 8.01,9.01
SCHEDULE 13G —
SCHEDULE 13G —
SCHEDULE 13G/A —
424B4
8-K 1.01,8.01,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.